knowledge -WSS

knowledge

author：entertainment 2025-08-12 09:12:34 - browse：72

Balance innovation — Medicare laid out in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be. Adobe

WASHINGTON — Medicare laid out Wednesday in the greatest detail yet how it will choose which drug prices it will negotiate in its brand-new program, and how it will figure out what the government’s opening offer will be.

Democrats outlined some parts of the process in the Inflation Reduction Act that passed Congress last August, but the details of how drugs will be selected and what factors will be considered have been vague until now. Though the actual negotiated prices won’t take effect for years, Medicare officials must announce the first 10 drugs they’ll negotiate over by Sept. 1.

The guidance clarifies that the agency will choose the 50 pharmacy drugs that cost Medicare the most money, based on gross expenditures. If drugs have the same cost to the program, then the one that has been approved longer will be ranked higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Colonoscopy at 40? Study finds a possible benefit

Wikipedia

knowledge

WSS

Medicare drug price negotiation’s day in court

Cloning humans is technically possible. It's curious no one has tried

Apple Vision Pro: A first look at health apps on the new VR headset

Cognito secures funding to test medical device for Alzheimer's

Colonoscopy at 40? Study finds a possible benefit

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Wikipedia

knowledge

Wikipedia

How to save PrEP access — and even expand it

What we need to know about Arena Bioworks

Sports medicine is finally prioritizing gender equality

The story of mRNA: From a loose idea to a tool that may help curb Covid

Moonlake's readout produced a cash windfall. Risks remain

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Do digital therapeutics have a future in medicine?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cloning humans is technically possible. It's curious no one has tried

hotspot

What would happen to your eyes if you looked at the solar eclipse?

SAMSHA loosens regulations on methadone treatment centers

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

STAT's guide to the next generation of CAR

CDC concerned about possible undetected monkeypox spread in U.K.

FDA drug safety: Singulair case shows systemic surveillance flaws

Wikipedia

Wikipedia

knowledge

focus